Literature DB >> 16236609

Inactivation of tumor suppressor genes and the progression of adult T-cell leukemia-lymphoma.

Y Yamada1, S Kamihira.   

Abstract

Almost three decades have passed since adult T-cell leukemia-lymphoma (ATLL) was proposed as a new disease entity. During this period, its causative agent, human T-cell leukemia virus type-1 (HTLV-1), was found and a crucial role of the viral product Tax in the development of ATLL was disclosed. However, the long latent period after infection with HTLV-1 indicates the need for additional factors for full-blown ATLL, most of which are supposed to be provided by somatic mutations of cellular genes. Recent progress in cell-cycle research has revealed that the uncontrolled and superior proliferative activity of malignant cells is mainly caused by the breakdown of cell-cycle regulation and that most malignancies carry aberrations in p16-pRB and/or p53 pathways. ATLL is not an exception, despite the consistent association of HTLV-1 in primary leukemia cells, and accumulating evidence indicates that the breakdown of these pathways is indeed involved in the leukemogenesis of ATLL, especially in its later steps, which serve as the key events for promotion of indolent ATLL to aggressive ATLL.

Entities:  

Mesh:

Year:  2005        PMID: 16236609     DOI: 10.1080/10428190500244217

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  12 in total

1.  Autocrine/paracrine cytokine stimulation of leukemic cell proliferation in smoldering and chronic adult T-cell leukemia.

Authors:  Jing Chen; Mike Petrus; Bonita R Bryant; Vinh Phuc Nguyen; Carolyn K Goldman; Richard Bamford; John C Morris; John E Janik; Thomas A Waldmann
Journal:  Blood       Date:  2010-09-21       Impact factor: 22.113

2.  Multiple Pathways Control the Reactivation of Telomerase in HTLV-I-Associated Leukemia.

Authors:  Marcia Bellon; Christophe Nicot
Journal:  Int J Cancer Oncol       Date:  2015-06-02

Review 3.  Adult T-cell leukemia/lymphoma and HTLV-1.

Authors:  Renaud Mahieux; Antoine Gessain
Journal:  Curr Hematol Malig Rep       Date:  2007-10       Impact factor: 3.952

4.  Absence of gain-of-function JAK1 and JAK3 mutations in adult T cell leukemia/lymphoma.

Authors:  T Kameda; K Shide; H K Shimoda; T Hidaka; Y Kubuki; K Katayose; Y Taniguchi; M Sekine; A Kamiunntenn; K Maeda; K Nagata; T Matsunaga; K Shimoda
Journal:  Int J Hematol       Date:  2010-08-10       Impact factor: 2.490

Review 5.  Implication of the HTLV-I bZIP factor gene in the leukemogenesis of adult T-cell leukemia.

Authors:  Yorifumi Satou; Masao Matsuoka
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

Review 6.  HTLV-1 Yin and Yang: Rex and p30 master regulators of viral mRNA trafficking.

Authors:  Hicham H Baydoun; Marcia Bellon; Christophe Nicot
Journal:  AIDS Rev       Date:  2008 Oct-Dec       Impact factor: 2.500

7.  TESTIN suppresses tumor growth and invasion via manipulating cell cycle progression in endometrial carcinoma.

Authors:  Zhenpeng Gu; Guofeng Ding; Kuixiang Liang; Hongtao Zhang; Guanghong Guo; Lili Zhang; Jinxiu Cui
Journal:  Med Sci Monit       Date:  2014-06-14

8.  Virus-associated lymphomagenesis.

Authors:  V Z Tarantul
Journal:  Int J Biomed Sci       Date:  2006-06

9.  Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma.

Authors:  Lee Ratner; William Harrington; Xuan Feng; Christian Grant; Steve Jacobson; Ariela Noy; Joseph Sparano; Jeannette Lee; Richard Ambinder; Nancy Campbell; Michael Lairmore
Journal:  PLoS One       Date:  2009-02-10       Impact factor: 3.240

Review 10.  Biology and Molecular Pathogenesis of Mature T-Cell Lymphomas.

Authors:  José R Cortés; Teresa Palomero
Journal:  Cold Spring Harb Perspect Med       Date:  2021-05-03       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.